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There is a growing need for technologies that enable discovery and validation of 
protein biomarkers in human serum/plasma. Antibody microarrays have been used 
successfully to rapidly identify and characterize protein expression in a targeted 
approach. In this study, antibody arrays were used to interrogate proteome differences 
in whole serum and in serum that had been depleted of twenty high abundance proteins. 
The depletion technology enhanced the identification of the lower abundance tissue 
leakage proteins, as compared to non-depleted serum samples. Antibody arrays were 
also used to profile differential protein expression between serum from normal and 
diseased patients. Proteins were identified which displayed significantly different 
expression levels between the samples. Results were validated with ELISA analysis.
This study showed that antibody arrays are a powerful tool for rapid expression 
profiling of proteins and may potentially be applied to biomarker discovery and 
validation in diseased serum samples.
